Threadgill Financial, LLC Merck & Co., Inc. Transaction History

Threadgill Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	BUY	$113.24 - $131.95 $23,893 - $27,841	211 Added 10.32%	2,256 $297,000
Q2 2023 Jul 12, 2023	BUY	$108.61 - $118.38 $2,823 - $3,077	26 Added 1.29%	2,045 $235,000
Q1 2023 Apr 13, 2023	BUY	$102.94 - $114.86 $1,955 - $2,182	19 Added 0.95%	2,019 $214,000
Q4 2022 Jan 30, 2023	SELL	$87.44 - $112.11 $255,149 - $327,136	-2,918 Reduced 59.33%	2,000 $221,000
Q4 2022 Jan 27, 2023	BUY	$87.44 - $112.11 $430,029 - $551,356	4,918 New	4,918 $0

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Threadgill Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Threadgill Financial, LLC with notifications on news.